or
forgot password
  • cancer clinical trials in rapid city, SD

  • Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Head and Neck Cancer
    Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Lymphoma
    Combination Chemotherapy in Treating Patients With Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Breast Cancer
    Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Gallbladder Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Genetic Study of Patients and Families With a History of Colorectal Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Colorectal Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Breast Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Bladder Cancer
    Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Brain and Central Nervous System Tumors
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Brain and Central Nervous System Tumors
    Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Kidney Cancer, Metastatic Cancer
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Head and Neck Cancer
    ICI 182780 in Treating Women With Metastatic Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Breast Cancer
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Prostate Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Black Hills Obstetrics & Gynecology LLP
    Rapid City, South Dakota 57701
    Endometrial Cancer
    Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Brain and Central Nervous System Tumors
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Black Hills Obstetrics and Gynecology
    Rapid City, South Dakota 57701
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Brain and Central Nervous System Tumors
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Fallopian Tube Cancer, Ovarian Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Black Hills Obstetrics and Gynecology
    Rapid City, South Dakota 57701
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Black Hills Obstetrics and Gynecology
    Rapid City, South Dakota 57701
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Gastrointestinal Stromal Tumor
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Rapid City, South Dakota 57701
    Neoplasms, Breast, Breast Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Brain and Central Nervous System Tumors
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Black Hills Obstetrics and Gynecology
    Rapid City, South Dakota 57701
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
    Oncology Associates at Rapid City Regional Hospital
    Rapid City, South Dakota 57701
    Breast Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Rapid City Regional Hospital
    Rapid City, South Dakota 57709
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Black Hills Obstetrics and Gynecology
    Rapid City, South Dakota 57701
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma